NanoVibronix, Inc. (NAOV)
NASDAQ: NAOV · Real-Time Price · USD
4.350
+0.050 (1.16%)
At close: May 5, 2025, 4:00 PM
4.170
-0.180 (-4.14%)
Pre-market: May 6, 2025, 5:33 AM EDT
NanoVibronix Employees
NanoVibronix had 31 employees as of December 31, 2024. The number of employees increased by 15 or 93.75% compared to the previous year.
Employees
31
Change (1Y)
15
Growth (1Y)
93.75%
Revenue / Employee
$82,516
Profits / Employee
-$119,516
Market Cap
3.30M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
NAOV News
- 24 days ago - NanoVibronix Regains Nasdaq Compliance - Business Wire
- 4 weeks ago - NanoVibronix Announces Renewal and Expansion of Distribution Agreement with Dukehill Healthcare Pty Ltd in Australia - Business Wire
- 7 weeks ago - Successful Independent Study of the NanoVibronix UroShield® Device Published in the Australian and New Zealand Continence Journal - Business Wire
- 7 weeks ago - NanoVibronix Announces Reverse Stock Split - Business Wire
- 2 months ago - NanoVibronix, Inc. Announces Acquisition of ENvue Medical Holdings, Corp. - Business Wire
- 4 months ago - NanoVibronix Advances Development of PainShield and UroShield with Completion of NextGen Prototypes - Business Wire
- 4 months ago - NanoVibronix Announces Completion of Pilot Phase of Clinical Study of UroShield® at the University of Michigan - Business Wire
- 5 months ago - NanoVibronix Secures $12 Million Minimum Purchase Commitment for PainShield with Extension of Distribution Agreement - Business Wire